ARCHIVES

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013

Radiation Dose Reconstruction Methods For Compensation Cases In Final Rule By HHS.

May 17, 2002

High Vitamin E Consumption Can Lower Liver Cancer Risks

July 27, 2012

Sentinel Node Disection No Worse Than Axillary

February 25, 2011